Healthy Life Agritec Limited held its 7th Annual General Meeting on September 26, 2026. The virtual meeting focused on adopting the audited financial statements for the fiscal year ended March 31, 2026.

Key resolutions passed

The members transacted four items of business during the proceedings. The primary agenda involved the adoption of both standalone and consolidated financial statements. Additionally, the board sought approval for material related party transactions for the upcoming fiscal year.

Meeting proceedings

The meeting commenced at 12:30 pm through Video Conferencing and Other Audio-Visual Means. Divya Mojjada, Managing Director, chaired the session and confirmed the presence of the requisite quorum. The notice and directors' report were taken as read, having been circulated in advance.

Remote e-voting facilities were available from September 23 to September 25, 2026. Members who did not vote remotely could cast their votes electronically during the live meeting. No questions were raised by shareholders during the open floor segment.

Governance and attendance

The following directors were present at the meeting:

• Divya Mojjada, Managing Director
• Mohammed Sadiq, Non-Independent Director
• Anil Kumar Vijay, Independent Director
• Apra Sharma, Independent Director

Rupal Kalsi served as the Company Secretary and Compliance Officer. Mayuri Sinha of Mayuri Sinha & Associates acted as the scrutinizer for the voting process. The meeting concluded at 12:45 pm.

Healthy Life Agritec will convene a Board of Directors meeting on September 29, 2026, to determine the specific terms of its proposed rights issue. The company had previously approved the fundraising plan for up to ₹5,000 lakh in a meeting held on September 23, 2026.

The upcoming session will focus on deciding the issue price, payment mechanism, rights entitlement ratio, and the record date. These decisions are subject to receipt of in-principle approval from BSE Limited. The rights issue involves issuing partly paid-up equity shares with a face value of ₹10 each to eligible shareholders.

Committee formation and meeting details

To oversee the execution of the rights issue, the Board has constituted a Rights Issue Committee. The committee members are:

1. Divya Mojjada – Chairperson
2. Mohammed Sadiq – Member
3. Apra Sharma – Member

The previous Board meeting commenced at 12:00 pm and concluded at 1:45 pm. The company informed BSE Limited about this development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The new intimation regarding the September 29 meeting was filed under Regulation 29 of the same regulations.

Trading window closure

In accordance with SEBI’s Prohibition of Insider Trading Regulations, the trading window for designated insiders and their immediate relatives remained closed. The closure began from the trading day following the initial intimation and continued until 48 hours after the conclusion of the September 23 board meeting. This regulatory step ensured compliance with insider trading norms during the period leading up to the disclosure of material information regarding the fundraising plan.

The number of equity shares to be issued will be determined after receiving in-principle approval from the Stock Exchange. The company’s registered office is located in Mira Road, Thane, while its corporate office and factory are in Doddaballapur, Bangalore.